Journal article

Intravenous iron or placebo for anaemia in intensive care: the IRONMAN multicentre randomized blinded trial

Edward Litton, Stuart Baker, Wendy N Erber, Shannon Farmer, Janet Ferrier, Craig French, Joel Gummer, David Hawkins, Alisa Higgins, Axel Hofmann, Bart De Keulenaer, Julie McMorrow, John K Olynyk, Toby Richards, Simon Towler, Robert Trengove, Steve Webb

Intensive Care Medicine | SPRINGER | Published : 2016

University of Melbourne Researchers


Funding Acknowledgements

Dr. Richards reports grants from the UK National Institute for Health Research (NIHR) Health Technology Assessment (HTA), the Australian National Health and Medical Research Council (NHMRC) and the UK National Institute of Academic Anaesthesia (NIAA)/British Journal of Anaesthesia (BJA)/Association of Cardiothoracic Anaesthetists (ACTA)/Vascular Anaesthesia Society of Great Britain and Ireland (VASGBI); grants, personal fees and non-financial support from Pharmocosmos, Vifor Pharma, Acelity and the Stroke Association; grants from Mason Medical Research Foundation and University College Hospital (UCH) League of Friends; grants and non-financial support from Libresse/Bodyform, outside the submitted work. TR is a regular speaker at national and international conferences on anaemia, blood transfusion, wound healing and vascular diseases for which he has received expenses for travel, accommodation and sundries. TR is a director of The Iron Clinic Ltd and director of Veincare London Ltd. TR is also the vascular lead for 18-Week Wait Ltd. Shannon Farmer reports personal fees from Thieme Stuttgart, Germany, and Elsevier Science USA, non-financial support from the National Blood Authority (Australia), the Medical Society for Blood Management and non-financial support from The Health Round Table, outside the submitted work. Dr. Hofmann reports personal fees from Vifor Pharma AG and TEM International GmbH, outside the submitted work. The other authors declare no conflict of interest.